{'Year': '2019', 'Month': 'Mar', 'Day': '19'}
Pharmacogenomic potential in advanced cancer patients.
The prevalence of pharmacogenetically actionable medications in advanced cancer patients whose therapy may be optimized with genotype data was determined.